Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats

Experimental and Molecular Pathology

Volumn 63, Issue 1, 1995, Pages 23-32

  Murakami, Shigeru ^a   Nara, Yasuo ^b   Yamori, Yukio ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029493539     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1995.1027     Document Type: Article

References (24)

1. Bennett Clark, S., and Tercyak, A. M. (1984). Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl Co A:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. 25, 148-159.
2. Bocan, T. M. A., Mueller, S. B., Uhlendorf, P. D., Brown, E. Q., Mazur, M. J., and Black, A. E. (1993). Inhibition of acyl-Co A cholesterol 0-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig. Atherosclerosis 99, 175-186.
3. Brecher, P. I., and Chobanian, A. V. (1974). Cholesteryl ester synthesis in normal and atherosclerotic aortas of rabbit and rhesus monkeys. Circ. Res. 35, 692-701.
4. Carr, T. P., Hamilton, R. L., Jr., and Rudel, L. L. (1995). ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J. Lipid Res. 36, 25-36.
5. Faggiotto, A., Ross, R., and Harker, L, (1984). Studies on hypercholesterolemia in nonhuman primate. I. changes that lead to fatty streak formation. Arteriosclerosis 4, 323-340.
6. Gerrity, R. G. (1981). The role of the monocyte in atherosclerosis: I. transition of blood-borne monocytes into foam cells in fatty lesions. Amer. J. Pathol. 103, 181-190.
7. Harris, W. S., Dujovne, C. A., Bergmann, K., Neal, J., Akester, J., Windsor, S. L., Greene, D., and Look, Z. (1990). Effects of the ACAT inhibitor CL277, 082 on cholesterol metabolism in humans. Clin. Pharmacol. Ther. 48, 189-194.
8. Hashimoto, S., and Dayton, S. (1977). Studies of the mechanism of augmented synthesis of cholesteryl ester in atherosclerotic rabbit aortic microsomes. Atherosclerosis 28, 447-452.
9. Haugen, R., and Norum, K. R. (1976). Coenzyme-A-dependent estérification of cholesterol in rat intestinal mucosa. Scand. J. Gastroenterol. 11, 615-62E
10. Heider, J. G., Pickens, C. E., and Kelly, L. A. (1983). Role of acyl Co A:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J. Lipid Res. 24, 1127-1134.
11. Helgerud, P., Saarem, K., and Norum, K. R. (1981). Acyl-Co A:cholesterol acyltransferase in human small intestine: Its activity and some properties of the enzyme reaction, J. Lipid Res. 22, 271-277.
12. Khan, B., Wilcox, H. G., and Heimberg, M. (1989). Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Biochem. J. 259, 807-816.
13. Krause, B. R., and Newton, R. J. (1985). Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats. J. Lipid Res. 26, 940-949.
14. Krause, B. R., Black, A., Bousley, R., Essenburg, A., Cornjcelli, J., Holmes, A., Homan, R., Kieft, K., Sekerke, C., Shaw-Hes, M. K., Stanfield, R., Trivedi, B., and Woolf, T. (1993a). Divergent pharmacologic activities of PD132301-2 and CL277, 082, urea inhibitor of acyl-Co A:cholesterol acyltransferase. J. Pharmacol. Exp. Ther.267, 734-743.
15. Krause, B. R., Anderson, M., Bisgaier, C. L., Bocan, T., Bousley, R., De Hart, P., Essenburg, A., Hamelehle, K., Homan, R., Kieft, K., Mc Nally, W., Stanfield, R., and Newton, R. S. (1993b). In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J. Lipid Res. 34, 279-294.
16. Largis, E. E., Wang, C. H., De Vries, V. G., and Schaffer, S. A. (1989). CL277, 082: A novel inhibitor of ACAT-catalyzed cholesterol estérification and cholesterol absorption. J. Lipid Res. 30, 681-690.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chern. 193, 265-275.
18. Murakami, S., Araki, H., Otomo, S., Nara, Y., and Yamori, Y. (1995a). Effects of HL-004, a novel ACAT inhibitor, on cholesterol accumulation and removal in cultured smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP). Life Sci. 56, 509-520.
19. Murakami, S., Nara, Y., and Yamori, Y. (1995b). Peritoneal macrophages from stroke-prone spontaneously hypertensive rats accumulate more cholesteryl ester than do macrophages from Wistar-Kyoto rats. Biochem. Biophys. Res. Commun. 211, 547-553.
20. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28, 1379-1388.
21. Yamori, Y., Hamashima, Y., Horie, R., Handa, H., and Sato, M. (1975). Pathogenesis of acute arterial fat deposition in spontaneously hypertensive rats. Jap. Cire. J. 39, 601-609.
22. Yamori, Y., Horie, R., Sato, M., and Fukase, M. (1976). Hypertension as an important factor for cerebrovascular atherogenesis in rats. Stroke 7, 120-125.
23. Yamori, Y., Nara, Y., Mano, M., Nabika, T., Ikeda, K., and Horie, R. (1989). Cellular proliferation: Common mechanism in hypertension and atherosclerosis. In “Hypertension and Atherosclerosis” (C. Dal Palu and R. Ross, Eds.), pp. 54-69. Excerpta Medica, Amsterdam.
24. Yanagita, T., Sonda, K., Yamamoto, K., Yotsumoto, H., and Murakami, S. (1995). Effect of a new acyl-Co A: cholesterol acyltransferase (ACAT) inhibitor HL-004 on cholesterol estérification and lipid metabolism in Hep G2 cells. Curr. Ther. Res. 56, 787-795.